Condition: Fibromyalgia (FM) · Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
The aim of this observational study is to evaluate the effects of cannabis extract Avextra 10/10 solution on pain, fatigue, sleep, and quality of life among patients affected by fibromyalgia (FM) syndrome. The main question it aims to answer is: Does cannabis extract have a positive effect on pain after 12 weeks in these patients? Participants diagnosed from FM will be evaluated and will fill survey about their pain, fatigue, sleep, anxiety, depression and quality of life at baseline, 4 weeks, 8 weeks and 12 weeks after the initiation of cannabis extract Avextra 10/10 solution.
This description comes directly from the study's public registry record.
Greta Pellegrino, Medical Doctor · 0283500010 · greta.pellegrino@grupposandonato.it
Piercarlo Sarzi Puttini, Medical Doctor · 0283500010 · piercarlo.sarziputtini@grupposandonato.it
Always discuss trial participation with your own doctor first.
| IRCCS Ospedale Galeazzi-Sant'Ambrogio | Milan, Milano, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06747039